Skip Navigation


Cardiovascular Research Advance Access first published online on May 16, 2008
This version [Corrected Proof] published online on May 20, 2008

Cardiovascular Research, doi:10.1093/cvr/cvn109
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
79/1/5    most recent
cvn109v2
cvn109v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Cardiovasc Res
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Goldstein, R. E.
Right arrow Articles by Haigney, M. C.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, R. E.
Right arrow Articles by Haigney, M. C.P.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Heart-rate reduction and beta blockade in early post-infarction cardiac remodelling

Robert E. Goldstein* and Mark C.P. Haigney

Cardiology Division, Department of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4799, USA

* Corresponding author. Tel: +1 301 295 3601; fax: +1 301 295 3557. E-mail address: rgoldstein@usuhs.mil

This editorial refers to ‘Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart’ by Maczewski M and Mackiewitz U, doi:10.1093/cvr/cvn057

The first 10% of the full text of this article appears below.

Soon after acute myocardial infarction, the heart may experience extensive changes in function, structure, tissue architecture, and biochemical properties collectively known as cardiac remodelling. Many of the deleterious changes can be attenuated by treatment with beta-adrenergic blocking agents1–3 or with alternative drugs that reduce post-infarction heart rate without interrupting beta-adrenergic signalling.4,5 In a study appearing in this issue of Cardiovascular Research,6 Maczewski and Mackiewitz employed a rat model to elucidate the benefits of post-infarction beta blockade by comparing effects of heart-rate reduction without beta blockade (using ivabradine) and effects observed when the same reduction in heart rate was . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Cardiovasc Res:

Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart
Michal Maczewski and Urszula Mackiewicz
Cardiovasc Res 2008 79: 42-51. [Abstract] [FREE Full Text]  

Related Article

Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart
Michal Maczewski and Urszula Mackiewicz
Cardiovasc Res 2008 79: 42-51. [Abstract] [Full Text] [PDF]